Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Navarro-Compán V, Sepriano A, El-Zorkany B, van der Heijde D (2021) Axial spondyloarthritis. Ann Rheum Dis 80:1511–1521. https://doi.org/10.1136/annrheumdis-2021-221035
Trouvin AP, Attal N, Perrot S (2022) Assessing central sensitization with quantitative sensory testing in inflammatory rheumatic diseases: a systematic review. Jt Bone Spine 89:105399. https://doi.org/10.1016/j.jbspin.2022.105399
Strand V, Deodhar A, Alten R, Sullivan E, Blackburn S, Tian H, Gandhi KK, Jugl SM, Conaghan PG (2021) Pain and fatigue in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: multinational real-world findings. J Clin Rheumatol 27:446–455. https://doi.org/10.1097/RHU.0000000000001544
Salaffi F, Giacobazzi G, Di Carlo M (2018) Chronic pain in inflammatory arthritis: mechanisms, metrology, and emerging targets-a focus on the JAK-STAT pathway. Pain Res Manag 2018:8564215. https://doi.org/10.1155/2018/8564215
den Boer C, Dries L, Terluin B, van der Wouden JC, Blankenstein AH, van Wilgen CP, Lucassen P, van der Horst HE (2019) Central sensitization in chronic pain and medically unexplained symptom research: a systematic review of definitions, operationalizations and measurement instruments. J Psychosom Res 117:32–40. https://doi.org/10.1016/j.jpsychores.2018.12.010
Nijs J, George SZ, Clauw DJ, FernandezdelasPenas C, Kosek E, Ickmans K (2021) Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. Lancet Rheumatol 3:383–392. https://doi.org/10.1016/S2665-9913(21)00032-1
Guler MA, Celik OF, Ayhan FF (2020) The important role of central sensitization in chronic musculoskeletal pain seen in different rheumatic diseases. Clin Rheumatol 39:269–274. https://doi.org/10.1007/s10067-019-04749-1
Adami G, Gerratana E, Atzeni F, Benini C, Vantaggiato E, Rotta D, Idolazzi L, Rossini M, Gatti D, Fassio A (2021) Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? Ther Adv Musculoskelet Dis 13:1759720X21993252. https://doi.org/10.1177/1759720X21993252
Vergne-Salle P, Bertin P (2021) Chronic pain and neuroinflammation. Jt Bone Spine 88:105222. https://doi.org/10.1016/j.jbspin.2021.105222
Kieskamp SC, Paap D, Carbo MJG, Wink F, Bos R, Bootsma H, Arends S, Spoorenberg A (2021) Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis. Rheumatology (Oxford) 60:4476–4485. https://doi.org/10.1093/rheumatology/keab019
Aykurt Karlıbel I, Kasapoğlu Aksoy M (2023) The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis. Ir J Med Sci 192:481–489. https://doi.org/10.1007/s11845-022-02957-4
Kieskamp SC, Paap D, Carbo MJG, Wink F, Bos R, Bootsma H, Arends S, Spoorenberg A (2022) Central sensitization has major impact on quality of life in patients with axial spondyloarthritis. Semin Arthritis Rheum 52:151933. https://doi.org/10.1016/j.semarthrit.2021.11.006
Yücel FN, Duruöz MT (2022) Central sensitization in axial spondyloarthritis: an explorative study with quantitative sensory testing and clinical scales. Mod Rheumatol 32:1137–1145. https://doi.org/10.1093/mr/roab110
Adams LM, Turk DC (2018) Central sensitization and the biopsychosocial approach to understanding pain. J Appl Biobehav Res 23:e12125. https://doi.org/10.1111/jabr.12125
Adams LM, Turk DC (2015) Psychosocial factors and central sensitivity syndromes. Curr Rheumatol Rev 11:96–108. https://doi.org/10.2174/1573397111666150619095330
Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M (2009) New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis 68:784–788. https://doi.org/10.1136/ard.2008.101501
van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368. https://doi.org/10.1002/art.1780270401
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J Rheumatol 21:2286–2291. https://doi.org/10.1002/art.1780270401
Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the bath ankylosing spondylitis disease activity index: reliability and validity. Rheumatol Int 25:280–284. https://doi.org/10.1007/s00296-003-0432-y
Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, Landewé R, van ver Tempel H, Mielants H, Dougados M, van der Heijde D (2003) Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 62:127–132. https://doi.org/10.1136/ard.62.2.127
Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P, Jenkinson T (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285
Ozer HT, Sarpel T, Gulek B, Alparslan ZN, Erken E (2005) The Turkish version of the Bath Ankylosing Spondylitis Functional Index: reliability and validity. Clin Rheumatol 24:123–128. https://doi.org/10.1007/s10067-004-0984-6
Doward LC, Spoorenberg A, Cook SA, Whalley D, Helliwell PS, Kay LJ, McKenna SP, Tennant A, van der Heijde D, Chamberlain MA (2003) Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Ann Rheum Dis 62:20–26. https://doi.org/10.1136/ard.62.1.20
Duruöz MT, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M, Tas N, Ozgocmen S, Yoleri O, Durmaz B, Oncel S, Tuncer T, Sendur O, Birtane M, Tuzun F, Bingol U, Kirnap M, Celik Erturk G, Ardicoglu O, Memis A, Atamaz F, Kizil R, Kacar C, Gurer G, Uzunca K, Sari H (2013) Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int 33:2717–2722. https://doi.org/10.1007/s00296-013-2796-y
Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ, Perez Y, Gatchel RJ (2012) The development and psychometric validation of the central sensitization inventory. Pain Pract 12:276–285. https://doi.org/10.1111/j.1533-2500.2011.00493.x
Düzce Keleş E, Birtane M, Ekuklu G, Kılınçer C, Çalıyurt O, Taştekin N, Is EE, Ketenci A, Neblett R (2021) Validity and reliability of the Turkish version of the central sensitization inventory. Arch Rheumatol 36:518–526. https://doi.org/10.46497/ArchRheumatol.2022.8665
Neblett R, Hartzell MM, Mayer TG, Cohen H, Gatchel RJ (2017) Establishing clinically relevant severity levels for the central sensitization inventory. Pain Pract 17:166–175. https://doi.org/10.1111/papr.12440
Zimet GD, Dahlem NW, Zimet SG, Farley GK (1988) The Multidimensional scale of social support. J Pers Assess 52:30–41
Eker D, Arkar H (1995) Perceived social support: psychometric properties of the MSPSS in normal and pathological groups in a developing country. Soc Psychiatry Psychiatr Epidemiol 30:121–126. https://doi.org/10.1007/BF00802040
Broadbent E, Petrie KJ, Main J, Weinman J (2006) The brief illness perception questionnaire. J Psychosom Res 60:631–637. https://doi.org/10.1016/j.jpsychores.2005.10.020
Oflaz S, Yüksel Ş, Şen F, Özdemiroğlu F, Kurt R, Oflaz H, Kaşikcioğlu E (2014) Does illness perception predict posttraumatic stress disorder in patients with myocardial infarction? Noro Psikiyatr Ars 51:103–109. https://doi.org/10.4274/npa.y6394
Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Aydemir O, Guvenir T, Kuey L, Kultur S (1997) Validity and reliability of Turkish version of hospital anxiety and depression scale. Turk J Psychiatry 8:280–287
Jenkins CD, Stanton BA, Niemcryk SJ, Rose RM (1988) A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol 41:313–321. https://doi.org/10.1016/0895-4356(88)90138-2
Duruoz MT, Ulutatar F, Ozturk EC, Unal-Ulutatar C, Sanal Toprak C, Kayhan O (2019) Assessment of the validity and reliability of the Jenkins sleep scale in ankylosing spondylitis. Int J Rheum Dis 22:275–279. https://doi.org/10.1111/1756-185X.13447
Coskun Benlidayi I (2020) Fibromyalgia interferes with disease activity and biological therapy response in inflammatory rheumatic diseases. Rheumatol Int 40:849–858. https://doi.org/10.1007/s00296-019-04506-2
Coskun Benlidayi I (2020) The effectiveness and safety of electrotherapy in the management of fibromyalgia. Rheumatol Int 40:1571–1580. https://doi.org/10.1007/s00296-020-04618-0
Nijs J, Leysen L, Vanlauwe J, Logghe T, Ickmans K, Polli A, Malfliet A, Coppieters I, Huysmans E (2019) Treatment of central sensitization in patients with chronic pain: time for change? Expert Opin Pharmacother 20:1961–1970. https://doi.org/10.1080/14656566.2019.1647166
Clark JR, Nijs J, Yeowell G, Holmes P, Goodwin PC (2019) Trait sensitivity, anxiety, and personality are predictive of central sensitization symptoms in patients with chronic low back pain. Pain Pract 19:800–810. https://doi.org/10.1111/papr.12809
Bilika P, Nijs J, Fandridis E, Dimitriadis Z, Strimpakos N, Kapreli E (2022) In the shoulder or in the brain? Behavioral, psychosocial and cognitive characteristics of unilateral chronic shoulder pain with symptoms of central sensitization. Healthcare (Basel) 10:1658. https://doi.org/10.3390/healthcare10091658
Campbell CM, Buenaver LF, Finan P, Bounds SC, Redding M, McCauley L, Robinson M, Edwards RR, Smith MT (2015) Sleep, pain catastrophizing, and central sensitization in knee osteoarthritis patients with and without insomnia. Arthritis Care Res (Hoboken) 67:1387–1396. https://doi.org/10.1002/acr.22609
Zhao SS, Jones GT, Hughes DM, Moots RJ, Goodson NJ (2021) Depression and anxiety symptoms at TNF inhibitor initiation are associated with impaired treatment response in axial spondyloarthritis. Rheumatology (Oxford) 60:5734–5742. https://doi.org/10.1093/rheumatology/keab242
Betegnie AL, Gauchet A, Lehmann A, Grange L, Roustit M, Baudrant M, Bedouch P, Allenet B (2016) Why do patients with chronic inflammatory rheumatic diseases discontinue their biologics? An assessment of patients’ adherence using a self-report questionnaire. J Rheumatol 43:724–730. https://doi.org/10.3899/jrheum.150414
Macfarlane GJ, Rotariu O, Jones GT, Pathan E, Dean LE (2020) Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS). Ann Rheum Dis 79:202–208. https://doi.org/10.1136/annrheumdis-2019-216143
Wilk M, Łosińska K, Pripp AH, Korkosz M, Haugeberg G (2022) Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatol Int 42:669–682. https://doi.org/10.1007/s00296-021-05070-4
Nijs J, Loggia ML, Polli A, Moens M, Huysmans E, Goudman L, Meeus M, Vanderweeën L, Ickmans K, Clauw D (2017) Sleep disturbances and severe stress as glial activators: key targets for treating central sensitization in chronic pain patients? Expert Opin Ther Targets 21:817–826. https://doi.org/10.1080/14728222.2017.1353603
Coskun Benlidayi I (2018) Sleep impairment: an obstacle to achieve optimal quality of life in rheumatoid arthritis. Rheumatol Int 38:2183–2192. https://doi.org/10.1007/s00296-018-4155-5
Schuh-Hofer S, Wodarski R, Pfau DB, Caspani O, Magerl W, Kennedy JD, Treede RD (2013) One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain 154:1613–1621. https://doi.org/10.1016/j.pain.2013.04.046